Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical Implications
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-23
DOI
10.3389/fonc.2020.549850
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma
- (2019) Hong Tang et al. ONCOGENE
- Epigenetic therapy for ovarian cancer: promise and progress
- (2019) Sara Moufarrij et al. Clinical Epigenetics
- Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma
- (2019) Zhiming Dong et al. CLINICAL & EXPERIMENTAL METASTASIS
- DNMT Inhibitors Increase Methylation in the Cancer Genome
- (2019) Anil K. Giri et al. Frontiers in Pharmacology
- Synergistic Antioncogenic Activity of Azacitidine and Curcumin in Myeloid Leukemia Cell Lines and Patient Samples
- (2019) IVÁN MARTÍN et al. ANTICANCER RESEARCH
- Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma
- (2019) Lehang Lin et al. Cancers
- Aberrant methylation of EYA4 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
- (2018) Mei Luo et al. CANCER SCIENCE
- Multiple roles of single-minded 2 in esophageal squamous cell carcinoma and its clinical implications
- (2018) Masashi Tamaoki et al. CANCER SCIENCE
- Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients
- (2018) De-Chen Lin et al. GASTROENTEROLOGY
- A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma
- (2018) Roshni Roy et al. INTERNATIONAL JOURNAL OF CANCER
- The Key Role of Epigenetics in Human Disease Prevention and Mitigation
- (2018) Andrew P. Feinberg NEW ENGLAND JOURNAL OF MEDICINE
- RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression
- (2018) Xiao-Yan Ming et al. Theranostics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
- (2018) Johanna Klughammer et al. NATURE MEDICINE
- Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population
- (2018) Chenji Wang et al. Frontiers in Genetics
- Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma
- (2018) Dong Jiang et al. Cell Death & Disease
- PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma
- (2017) Keisuke Kurimoto et al. Epigenetics
- Genomic hallmarks of localized, non-indolent prostate cancer
- (2017) Michael Fraser et al. NATURE
- DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
- (2017) Nathan C Sheffield et al. NATURE MEDICINE
- Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition
- (2017) Xuexiao Wang et al. Oncotarget
- Intratumoral Heterogeneity of the Epigenome
- (2016) Tali Mazor et al. CANCER CELL
- Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma
- (2016) Jia-Jie Hao et al. NATURE GENETICS
- Epigenome-based personalized medicine in human cancer
- (2016) Wenji Yan et al. Epigenomics
- Genome–Wide Hypomethylation and Specific Tumor-Related Gene Hypermethylation are Associated with Esophageal Squamous Cell Carcinoma Outcome
- (2015) Sojun Hoshimoto et al. Journal of Thoracic Oncology
- Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma
- (2015) Zhenzong Du et al. World Journal of Surgical Oncology
- Promoter Methylation of MGMT Gene in Serum of Patients with Esophageal Squamous Cell Carcinoma in North East India
- (2015) Mandakini Das et al. Asian Pacific Journal of Cancer Prevention
- Chromosomal Instability Associated with Global DNA Hypomethylation is Associated with the Initiation and Progression of Esophageal Squamous Cell Carcinoma
- (2014) Hiroyuki Kawano et al. ANNALS OF SURGICAL ONCOLOGY
- Locally Disordered Methylation Forms the Basis of Intratumor Methylome Variation in Chronic Lymphocytic Leukemia
- (2014) Dan A. Landau et al. CANCER CELL
- Epigenetics in esophageal cancers
- (2014) Theresa D. Ahrens et al. CELL AND TISSUE RESEARCH
- LINE-1 Hypomethylation, DNA Copy Number Alterations, andCDK6Amplification in Esophageal Squamous Cell Carcinoma
- (2014) Yoshifumi Baba et al. CLINICAL CANCER RESEARCH
- Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer
- (2014) Rafael Guerrero-Preston et al. Epigenetics
- DNA methylation is a key factor in understanding differentiation phenotype in esophageal squamous cell carcinoma
- (2014) Masayuki Komatsu et al. Epigenomics
- Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma
- (2013) Dongli Yue et al. EXPERIMENTAL CELL RESEARCH
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma
- (2013) Yaoyao Su et al. MEDICAL ONCOLOGY
- A review of the alterations in DNA methylation in esophageal squamous cell carcinoma
- (2013) Yoshifumi Baba et al. SURGERY TODAY
- LINE-1 Hypomethylation Is Associated With a Poor Prognosis Among Patients With Curatively Resected Esophageal Squamous Cell Carcinoma
- (2012) Shiro Iwagami et al. ANNALS OF SURGERY
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- Rab25 Is a Tumor Suppressor Gene with Antiangiogenic and Anti-Invasive Activities in Esophageal Squamous Cell Carcinoma
- (2012) M. Tong et al. CANCER RESEARCH
- Intratumor Heterogeneity: Evolution through Space and Time
- (2012) C. Swanton CANCER RESEARCH
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma
- (2012) Ji-Sheng Li et al. Chinese Journal of Cancer
- Hypermethylation-modulated Downregulation of RASSF1A Expression Is Associated with the Progression of Esophageal Cancer
- (2011) Wei-min Mao et al. ARCHIVES OF MEDICAL RESEARCH
- Aberrant Methylation of Different DNA Repair Genes Demonstrates Distinct Prognostic Value for Esophageal Cancer
- (2011) Zhi-Qiang Ling et al. DIGESTIVE DISEASES AND SCIENCES
- Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers
- (2011) Sheila C.S. Lima et al. Epigenetics
- Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer
- (2011) Devasena Anantharaman et al. ORAL ONCOLOGY
- Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma
- (2011) Ji-Bin Liu WORLD JOURNAL OF GASTROENTEROLOGY
- Aberrant methylation of the 3q25 tumor suppressor genePTX3in human esophageal squamous cell carcinoma
- (2011) Jun-Xiong Wang WORLD JOURNAL OF GASTROENTEROLOGY
- KRAB Zinc Finger Protein ZNF382 Is a Proapoptotic Tumor Suppressor That Represses Multiple Oncogenes and Is Commonly Silenced in Multiple Carcinomas
- (2010) Y. Cheng et al. CANCER RESEARCH
- Promoter methylation ofHIN-1in the progression to esophageal squamous cancer
- (2010) MingZhou Guo et al. Epigenetics
- Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles
- (2010) F. Tanaka et al. GUT
- Cigarette smoke induces promoter methylation of single-stranded DNA-binding protein 2 in human esophageal squamous cell carcinoma
- (2010) Yiping Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Qualitative analysis of Adenomatous Polyposis Coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker
- (2009) Maryam Zare et al. BMC CANCER
- Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growthin vitroandin vivo
- (2009) Lin-Wei Li et al. INTERNATIONAL JOURNAL OF CANCER
- The impact of retrotransposons on human genome evolution
- (2009) Richard Cordaux et al. NATURE REVIEWS GENETICS
- DNA hypomethylation in cancer cells
- (2009) Melanie Ehrlich Epigenomics
- Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus
- (2008) Y. T. Kim et al. DISEASES OF THE ESOPHAGUS
- Clonality, Founder Mutations, and Field Cancerization in Human Ulcerative Colitis–Associated Neoplasia
- (2008) Simon J. Leedham et al. GASTROENTEROLOGY
- Epigenetic drivers and genetic passengers on the road to cancer
- (2008) Carla Sawan et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now